NFE2L2 and prostate carcinoma: Furthermore, antioxidants including nuclear factor erythroid 2-related factor 2 (Nrf2) and its target gene glutathione-S-transferase (GST) have been shown to be suppressed in prostate cancer, which may exacerbate the initial insult from obesity (124).